Evidence map›Paper›PMID 31537479›Full record

ArticleJournal of the American Medical Directors Association2020

Antibiograms Cannot Be Used Interchangeably Between Acute Care Medical Centers and Affiliated Nursing Homes.

Maria-Stephanie A Hughes, David M Dosa, Aisling R Caffrey, Haley J Appaneal, Robin L P Jump, Vrishali Lopes, Kerry L LaPlante

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in Journal of the American Medical Directors Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04318613 (Antibiograms of Intensive Care Units at an Egyptian Tertiary Care Hospital), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04318613 completednot on this map

Antibiograms of Intensive Care Units at an Egyptian Tertiary Care Hospital

Typeobservational_patient_registrySponsorZagazig UniversityRan2019 to 2019Enrolled45,221ConditionsCritical Illness
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Are Antibiograms Ready for Prime Time in the Nursing Home?Journal of the American Medical Directors Association · 2020
    Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Maria-Stephanie A HughesInfectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI; Center of Innovation for Long Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI; University of Rhode Island, Department of Pharmacy Practice, College of Pharmacy, Kingston, RI.
David M DosaInfectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI; Center of Innovation for Long Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI; University of Rhode Island, Department of Pharmacy Practice, College of Pharmacy, Kingston, RI; School of Public Health, Brown University, Providence, RI.
Aisling R CaffreyInfectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI; Center of Innovation for Long Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI; University of Rhode Island, Department of Pharmacy Practice, College of Pharmacy, Kingston, RI; School of Public Health, Brown University, Providence, RI.
Haley J AppanealInfectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI; Center of Innovation for Long Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI; University of Rhode Island, Department of Pharmacy Practice, College of Pharmacy, Kingston, RI; School of Public Health, Brown University, Providence, RI.
Robin L P JumpGeriatric Research Education and Clinical Center (GRECC) and the Specialty Care Center of Innovation, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH; Division of Infectious Diseases and HIV Medicine, Department of Medicine and Department of Population & Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH.
Vrishali LopesInfectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI.
Kerry L LaPlanteInfectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI; Center of Innovation for Long Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI; University of Rhode Island, Department of Pharmacy Practice, College of Pharmacy, Kingston, RI; Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, RI. Electronic address: KerryLaPlante@uri.edu.

Funding

Improving Antimicrobial Stewardship in Veterans Affairs (VA) Community Living CentersI01HX001894 · VA · PROVIDENCE VA MEDICAL CENTER · PI DOSA, DAVID M., MD, MPH · 2018 to 2020
–
HSRD VA I01 HX001894HSRD VA IK2 HX002247
6 · The paper itself

Abstract

objectiveTo determine whether antibiograms for Veterans Affairs (VA) nursing homes (NHs), termed Community Living Centers, are similar to those from their affiliated acute care medical centers.

designDescriptive study. SETTING AND

participantsWe compared the 2017 antibiograms for VA NHs to their affiliated VA medical centers (VAMCs). Antibiograms included antibiotic susceptibility rates for commonly observed bacteria in this setting (Staphylococcus aureus, Enterococcus spp, Escherichia coli, Klebsiella spp, Proteus mirabilis, and Pseudomonas aeruginosa).

methodsAntibiograms were considered to be in complete agreement when the overall susceptibility rate between the NH and affiliated VAMC was either at or above 80% or below 80% across all bacteria and antibiotics. Average percentage of bacteria-antibiotic comparisons in disagreement per facility pair, and number of facilities with agreement for specific bacteria-antibiotic comparisons were also assessed. The chi-square test was used to compare disagreement between NH-VAMC facilities based on geographic proximity of the NH to the VAMC, culture source, and bed size.

resultsA total of 119 NH-VAMC affiliate pairs were included in this analysis, with 71% (84/119) on the same campus and 29% (35/119) on geographically distinct campuses. None of the NH-VAMC pairs demonstrated complete agreement (all bacteria vs all antibiotics) between their antibiograms. On average, 20% of the bacteria-antibiotic comparisons from the antibiogram disagreed clinically per NH-VAMC pair, and almost twice as often the nursing home had lower susceptibility (higher resistance) than the acute care facility. Some bacteria-antibiotic comparisons agreed in all facilities (eg, E coli-imipenem; S aureus-linezolid; S aureus-vancomycin), while others showed greater disagreement (eg, Klebsiella spp-cefazolin; Klebsiella spp-ampicillin-sulbactam; P aeruginosa-ciprofloxacin). Rates of clinical disagreement were similar by geographic proximity of the NH to the VAMC, culture source, and bed size. CONCLUSIONS AND IMPLICATIONS: Overall, this study showed a moderate lack of agreement between VA NH antibiograms and their affiliate VAMC antibiograms. Our data suggest that antibiograms of acute care facilities are often not accurate approximations of the nursing home resistance patterns and therefore should be used with caution (if at all) in guiding empiric antibiotic therapy.

Indexed as

HospitalsNursing HomesAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsUnited StatesUnited States Department of Veterans AffairsAnti-Bacterial AgentsAntibiogramantimicrobial stewardshipCommunity Living Centerempiric antibiotic therapyVeterans Affairs

Identifiers

PMID31537479
PMCPMC7233453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.